Latest
Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies|Cargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight LogisticsCargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight Logistics|Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies|Cargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight LogisticsCargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight Logistics
Back to articles

Corgi Raises $160M Series B to Build AI-Native Insurance Platform for Startups

Insurance has always had the same energy as fluorescent lighting in a DMV waiting room. Necessary. Expensive. Soul-numbing. Founders would rather explain cap tables to their in-laws than sit through another underwriting call where somebody asks if their AI company stores customer data. Of course they do. It’s 2026. Everybody stores customer data. Even your refrigerator’s building a profile on you. That’s why Corgi catching a fresh $160M Series B at a $1.3B valuation hits different.

Not because “AI” got stapled onto another pitch deck like parsley on bad steak. Because Nico Laqua and Emily Yuan looked at one of the oldest, slowest-moving industries on earth and decided the real risk wasn’t startups. It was the insurance process itself. The paperwork. The lag. The parade of brokers, carriers, emails, PDFs, signatures, delays, and “we’ll circle back next week” theater performances that somehow became normalized in commercial insurance.

TCV led the round, with support from investors including Kindred Ventures, Contrary, SV Angel, and others backing the company’s sprint toward becoming an AI-native, full-stack insurance carrier built specifically for startups. Not an add-on. Not a layer sitting on top of legacy infrastructure pretending to move fast while COBOL wheezes in the basement. An actual carrier. That distinction matters because most startups treat insurance like flossing. They know they need it, but nobody’s waking up excited to do it. Corgi turned that friction point into infrastructure. The company underwrites and issues policies directly while automating underwriting, claims, and policy operations through AI. Translation: less waiting, less operational drag, fewer middlemen treating urgency like a casual suggestion.

And the market clearly noticed. Corgi has now raised more than $268M since launching in 2024. ARR reportedly surpassed $40M after receiving regulatory approval in July 2025. In a market where insurtech funding has cooled harder than leftover airport coffee, Corgi didn’t just raise capital. They vacuumed attention out of the room.

That’s the part founders should study closely. Speed wins twice. First operationally. Then psychologically. Startups buy momentum before they buy perfection. Investors do too. Corgi understood that startups don’t want insurance designed for Fortune 500 procurement departments moving at fax-machine velocity. They want coverage that understands how modern companies actually operate. Fast decisions. Modular products. Infrastructure that feels built this decade.

Even the name works. Corgis are compact, fast, stubborn little machines with disproportionately big energy. Which honestly feels like the perfect metaphor for a startup walking into one of the most regulated industries in America and deciding it’s going to move at software speed anyway. That takes conviction. And probably a tolerance for regulatory meetings that could tranquilize a rhino mid-sprint.